Related Experiment Video
Updated: May 16, 2026

14:09
Quantitative Optical Microscopy: Measurement of Cellular Biophysical Features with a Standard Optical Microscope
Published on: April 7, 2014
Optical phase nanoscopy in red blood cells using low-coherence spectroscopy
Itay Shock1, Alexander Barbul, Pinhas Girshovitz
1Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv 69978, Israel.
Journal of Biomedical Optics
|December 11, 2012
Summary
We developed a new spectral-domain phase microscopy (SDPM) system to measure red blood cell (RBC) membrane changes. This system accurately quanties visco-elastic properties, aiding in disease monitoring.
Area of Science:
- Biomedical Optics
- Cellular Biophysics
- Medical Diagnostics
Background:
- Red blood cell (RBC) visco-elastic properties are crucial biomarkers for various diseases.
- Accurate, non-invasive methods are needed to monitor RBC health and disease progression.
- Current techniques may lack the sensitivity to detect subtle changes in RBC membrane dynamics.
Purpose of the Study:
- To introduce a novel low-coherence spectral-domain phase microscopy (SDPM) system.
- To enable accurate quantitative phase measurements of red blood cell (RBC) membrane fluctuations.
- To assess the potential of SDPM for disease prognosis and monitoring.
Main Methods:
- Developed and implemented a low-coherence spectral-domain phase microscopy (SDPM) system.
- Performed time-recordings of nano-scale cell membrane fluctuations in RBCs.
- Compared SDPM performance with wide-field digital interferometry (WFDI) for measuring low-amplitude fluctuations.
Main Results:
- SDPM accurately measured nano-scale fluctuations in RBC membranes.
- Glutaraldehyde-treated RBCs exhibited lower fluctuation amplitudes, indicating increased membrane stiffness.
- SDPM demonstrated superior optical-path-delay stability (<0.3 nm) compared to WFDI in liquid environments.
Conclusions:
- The SDPM system offers high accuracy and sensitivity for quantitative phase measurements of RBCs.
- The system's ability to detect changes in membrane stiffness holds promise for disease monitoring.
- SDPM's compact, robust, and inexpensive design makes it suitable for clinical applications.

